Biologic and Systemic Agents in Dermatology

Chapter 1 - Tumor Necrosis Factor Inhibition in the Treatment of Psoriasis and Psoriatic Arthritis

Chapter 2 - Therapies Targeting Interleukin-23 in Psoriatic Disease

Chapter 3 - Interleukin 17 - Pathogenesis in Psoriatic Disease and Treatment through Selective Blockade

Chapter 4 - Conventional Systemic Agents for Psoriatic Disease

Chapter 5 - The Role of JAK Kinase Inhibitors in Psoriatic Disease and Other Dermatologic Conditions

Chapter 6 - PDE4 Inhibition in the Treatment of Psoriasis Disease and Other Skin Conditions

Chapter 7 - Miscellaneous Use of Biologic and Systemic Agents in Other Dermatologic Conditions

Chapter 8 - Targeting Interleukin 4 and Interleukin 13 in the Treatment of Atopic Dermatitis

Chapter 9 - Oral Agents for Atopic Dermatitis

Chapter 10 - Role of Intravenous Immunoglobulin in Dermatologic Disorders

Chapter 11 - Selective Targeting of CD20 on B Cells in Pemphigus Vulgaris and Other Dermatologic Diseases

Chapter 12 - Oral Systemic Agents for Various Immunobullous Disorders

Chapter 13 - Anti-IgE Therapy in Dermatology

Chapter 14 - Oral Retinoids in Dermatology

Chapter 15 - Updates in Immunotherapies for Melanoma

Chapter 16 - Sonic Hedgehog Inhibition in the Treatment of Advanced BCC

Paul S. Yamauchi, M.D., Ph.D. is Clinical Assistant Professor of Dermatology, David Geffen School of Medicine at UCLA and Harbor-UCLA Medical Center and isdermatologist in private practice at the Dermatology Institute and Skin Care Center in Santa Monica, California. Dr. Yamauchi is a fellow with the American Academy of Dermatology and the American Society of Dermatology Surgery and is also a member of the Los Angeles Metropolitan Dermatologic Society and California Society of Dermatology and Dermatologic Surgery. He is the editor-in-chief of Dermatology Reports and is the author and co-author of more than 70 publications, including several books.
Dr. Yamauchi conducts numerous clinical research trials at the Clinical Science Institute in Santa Monica and serves as a principle investigator in several studies, including new therapies for psoriasis, skin cancer, eczema and acne, and has been a consultant for the development of new innovative therapies in dermatology. He is recognized as a key expert leader on psoriasis and has served on the Medical Board for the National Psoriasis Foundation and the Scientific Advisory Committee for the National Eczema Association. He has extensive experience using the new biologics, oral drugs, and topical medications in the treatment of psoriasis, and has been invited as a speaker at international, national, regional, and local venues to talk about new advances in the treatment of psoriasis and atopic dermatitis. In addition, he is a strong advocate in establishing patient support groups for psoriasis, and has published extensively in new advances in the treatment of psoriasis. Dr. Yamauchi has also spoken on other dermatologic conditions at national and local meetings and has published many peer-reviewed articles including acne, eczema, skin manifestations associated with rheumotologic conditions, and hyperhidrosis. He has given several television media interviews locally in Los Angeles as well as nationally on ESPN, national